HK Stock Movement | LEADS BIOLABS-B (09887) Rises Over 3% as Five Hematology Research Findings Presented at 2025 ASH Annual Meeting
Stock News
Nov 05
LEADS BIOLABS-B (09887) surged more than 3%, reaching HK$57.9 by the time of writing, with a trading volume of HK$20.2056 million. On November 4, the company announced that five research abstracts had been selected for presentation at the 67th Annual Meeting of the American Society of Hematology (ASH). The company shared further details about its investigational drugs, LBL-034 and LBL-076, with multiple research abstracts accepted by the ASH conference. Notably, one clinical study on LBL-034 was chosen as the first oral presentation on the opening day, showcasing the latest efficacy and safety data for LBL-034 in patients with relapsed/refractory multiple myeloma.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.